← Open Payments lookup

PAUL DAVANZO: Open Payments

NPI 1710749403 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,418 in 46 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $374 · 2025 $1,418

Food & beverage: $1,418
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$323
E.R. Squibb & Sons, L.L.C.6$217
Corium, LLC8$195
Janssen Pharmaceuticals, Inc3$189
Otsuka America Pharmaceutical, Inc.5$111
ABBVIE INC.5$109
Lundbeck LLC3$77
Bausch Health US, LLC3$60
Supernus Pharmaceuticals, Inc.2$33
Neos Therapeutics, LP1$31

Products named: CAPLYTA, COBENFY, Azstarys, SPRAVATO, REXULTI, VRAYLAR, APLENZIN, Qelbree.

Industry payments across NY — which companies pay providers there.